Results 91 to 100 of about 259,075 (330)
The role of immunomodulators in treatment-resistant depression: case studies
Cell Death Discovery, 2022 Depression is a common mental disorder affecting more than 264 million people worldwide. The first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (SSRIs), such as sertraline, reboxetine and fluoxetine.
Charles W. Beckett +1 more
doaj +1 more source
The Role of Vagus Nerve Stimulation in Depression: What We Know?
European Psychiatry, 2022 Introduction Depression is a leading cause of disability affecting over 300 million indivuals worldwide. About 1/3 of patients with depression fail to achive remission despite treatment with multiple antidepressants and are considered to have treatment ...
A. Fraga +7 more
doaj +1 more source
The body speaks its mind : the BodyMind Approach® for patients with medically unexplained symptoms in primary care in England [PDF]
, 2015 Date of Acceptance: 22/12/2014This article documents an experience of translating research into the real-world of the National Health Service (NHS) in the England.
Payne, Helen
core +1 more source
MOFs and COFs in Electronics: Bridging the Gap between Intrinsic Properties and Measured Performance
Advanced Functional Materials, EarlyView.Metal‐organic frameworks (MOFs) and covalent organic frameworks (COFs) hold promise for advanced electronics. However, discrepancies in reported electrical conductivities highlight the importance of measurement methodologies. This review explores intrinsic charge transport mechanisms and extrinsic factors influencing performance, and critically ...
Jonas F. Pöhls, R. Thomas Weitz
wiley +1 more source
Neuromodulation therapies and treatment-resistant depression
Medical Devices: Evidence and Research, 2012 Khalid Saad Al-Harbi,1 Naseem Akhtar Qureshi21National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia; 2General Administration for Research and Studies and Mental Health and Social Services, Riyadh, Saudi ArabiaBackground: Patients ...
Al-Harbi KS, Qureshi NA
doaj
Cushing's syndrome masquerading as treatment resistant depression
Indian Journal of Psychological Medicine, 2016 Treatment resistant depression (TRD) is a common clinical occurrence among patients treated for major depressive disorder. A significant proportion of patients remain significantly depressed in spite of aggressive pharmacological and psychotherapeutic ...
B N Anil Kumar, Sandeep Grover
doaj +1 more source
Ketamine: NMDA receptors and beyond [PDF]
, 2016 Human studies examining the effects of the dissociative anesthetic ketamine as a model for psychosis and as a rapidly acting antidepressant have spurred great interest in understanding ketamine's actions at molecular, cellular, and network levels ...
Izumi, Yukitoshi +2 more
core +2 more sources
Advanced Functional Materials, EarlyView.Molecular engineering of a nonconjugated radical polymer enables a significant enhancement of the glass transition temperature. The amorphous nature and tunability of the polymer, arising from its nonconjugated backbone, facilitates the fabrication of organic memristive devices with an exceptionally high yield (>95%), as well as substantial ...
Daeun Kim +14 more
wiley +1 more source
Excess deaths in treatment-resistant depression
Therapeutic Advances in Psychopharmacology, 2021 Background: Patients with treatment-resistant depression (TRD) have an increased mortality risk compared with other patients with depression, but it is not known how this translates into absolute numbers of excess deaths.
Philip Brenner +3 more
doaj +1 more source
Noninvasive vagus nerve stimulation alters neural response and physiological autonomic tone to noxious thermal challenge. [PDF]
, 2019 The mechanisms by which noninvasive vagal nerve stimulation (nVNS) affect central and peripheral neural circuits that subserve pain and autonomic physiology are not clear, and thus remain an area of intense investigation.
Baker, Dewleen G +13 more
core +2 more sources